Grenzen und Möglichkeiten der Therapie von Rhythmusstörungen im Hinblick auf den plötzlichen Herztod

• LITERATUR

• 1 Kuller L., Lilienfeld A., Fisher R.. Epidemiological study of sudden and unexpected deaths due to arteriosclerotic heart disease. Circulation 1966; 34: 1056-1068
• 2 Lown B.. Sudden cardiac death: The major challenge confronting contemporary cardiology. Am. J. Cardiol. 1979; 43: 313-328
• 3 Pantridge J., Geddes S.. A mobile intensive care unit in the management of myocardial infarction. Lancet 1967; 2: 271
• 4 Pantridge J. F.. Prehospital coronary care. Brit. Heart J. 1974; 26: 233-237
• 5 Iseri L., Humphrey S.. Prehospital brady-asysto-lic cardiac arrest. Ann. Intern. Med. 1978; 88: 741
• 6 Adgey A. A. J., Geddes J. S., Mülholland H. C., Keegan D. A. J., Pantridge J. F.. Incidence. significance and management of early brady-arrhythmias complicating acute myocardial infarction. Lancet 1968; 2: 1097
• 7 Bashe W. J., Baba N.. et al. Pathology of atherosclerotic heart disease in sudden death. II: The significance of myocardial infarction. Circulation 1975; 51/52 (Suppl. III) 63
• 8 Baroldi G., Falzi G., Mariani F.. Sudden coronary death. A postmortem study in 208 selected cases compared to 97 »control« subjects. Am. Heart J. 1979; 98: 20-31
• 9 Grace W. J.. Sudden death and acute myocardial infarction - what are we talking about (editorial). Am. Heart J. 1976; 91: 1-2
• 10 Lown B.. New concepts and approaches to sudden death. Schweiz med. Wschr. 1976; 106: 1522-1531
• 11 Reichenbach D. D., Moss N. S., Meyer E.. Pathology of the heart in sudden death. Am. J. Cardiol. 1977; 39: 865-872
• 12 Roberts W. L., Buja L. W.. The frequency and significance of coronary arterial thrombi and other observations in fatal acute myocardial infarction. Am. J. Med. 1972; 52: 425
• 13 Spain D. M., Brades V. A.. Frequency of coronary thrombi as related to duration of survival from onset of acute fatal episodes of myocardial isch-aemia. Circulation 1960; 22: 816
• 14 Lovegrove T., Thompson P.. The role of acute myocardial infarction in sudden cardiac death - a statistician nightmare. Am. Heart J. 96: 711 1978;
• 15 Weaver W. D.. et al Angiographic findings and prognostic indicators in patients resuscitated from sudden death. Circulation 1976; 54: 895
• 16 Cobb L. A., Hallstrom A. P.. et al: Prognostic factors in patients resuscitated from sudden cardiac death. In Hjalmarson A. L., Wilhelmsen L.. (eds) Acute and longterm medical treatment of myocardial ischaemia. Hässl, Mölntal 1978
• 17 Schaffer W. A., Cobb L. A.. Recurrent ventricular fibrillation and modes of death in survivors of out of hospital ventricular fibrillation. New Engl. J. Med. 1975; 293: 259-262
• 18 Wellens H. J. J., Düren D. R., Lie K. J.. Observations on mechanism of ventricular tachycardia in man. Circulation 1976; 54: 237
• 19 Myberg R. J., Steward J. W., Hoffman B. I.. Electrophysical properties of the canine peripheral av - conducting system. Circulation Res. 1970; 26: 361
• 20 Lown B., Wolf M.. Approaches to sudden death from coronary heart disease. Circulation 1971; 44: 130
• 21 van Durme J. P., Pannier R.. Prevalence and prognostic significance of ventricular dysrhythmias during the first year after myocardial infarction. In Mäurer W. A., Schöming R., Dietz P., Lichtlen R.. (eds.) Betablockade 1977. Thieme; Stuttgart: 1978: 286
• 22 Ruberman W., Weinblatt E.. et al. Prognostic value of one hour of EKG-monitoring of man with coronary heart disease. J. chron. Dis. 1976; 29: 497-512
• 23 Schulze R. A., Strauss H. W., Pitt B.. Sudden death in the year following myocardial infarction. Am. J. Med. 1977; 62: 192
• 24 Vismara L. A., Amsterdam E. A., Mason D. T.. Relation of ventricular arrhythmias in the late hospital phase of acute myocardial infarction to sudden death of hospital discharge. Am. J. Med. 1975; 59: 6
• 25 The Coronary Drug Project Research Group Prognostic importance of premature beats following myocardial infarction. Experience in the coronary drug project. JAMA 1973; 223: 1116
• 26 Ruberman W. E., Weinblatt E., Goldberg J. D.. et al. Ventricular premature beats and mortality after myocardial infarction. New Engl. J. Med. 1977; 297: 750
• 27 El Sherif N., Myerburg R. J., Scherlag J., Befeler B., Aranda J. M., Castellanos A., Lazzara R.. Electrocardiographic antecedents of primary ventricular fibrillation. Value of the R on T-phenomenon in myocardial infarction. Brit. Heart J. 1976; 38: 415
• 28 Bennet M. A., Pentecost B. L.. Warning of cardiac arrest due to ventricular fibrillation and tachycardia. Lancet 1972; 1: 1351
• 29 Lie K. J., Wellens H. J. J., Durrer D.. Characteristics and predictability of primary ventricular fibrillation. Europ. J. Cardiol. 1974; 1: 379
• 30 Lie K. J., Wellens H. J. J., Dorner E., Durrer D.. Observations in patients with primary ventricular fibrillation complicating acute myocardial infarction. Circulation 1975; 52: 755
• 31 Seipel L.. Warnarrhythmien und Lidocainpro-phylaxe beim Herzinfarkt. Dtsch. med. Wschr. 1977; 102: 1041-1042
• 32 Califf R. M., Burks J. M.. et al. Relationship among ventricular arrhythmias. Coronary artery disease and angiographic and electrocardiographic indicators of myocardial fibrosis. Circulation 1978; 57: 725
• 33 Calvert A., Lown B., Gorlin R.. Ventricular premature beats and anatomically defined coronary heart disease. Am. J. Cardiol. 1977; 39: 627-634
• 34 Lichtlen P. R., Bethge K. P., Platiel H.. Inzidenz des plötzlichen Herztodes bei Koronarpatienten in Abhängigkeit von Anatomie und Rhythmus-profil. Z. Kardiol. 1980; 69: 639-648
• 35 Sharma S. D., Ballantyne F., Goldstein S.. The relationship of ventricular asynergy in coronary artery disease to ventricular premature beats. Chest 1974; 66: 358-362
• 36 Schulze R. A., Humphries J., O'Neal J.. Left ventricular and coronary angiographic anatomy -relationship to ventricular irritability in the late hospital phase of acute myocardial infarction. Circulation 1977; 55: 839
• 37 Matta R. J., Verrier R. L., Lown B.. The repetitive extrasystole as an index of vulnerability to ventricular fibrillation. Am. J. Physiol. 1976; 230: 1469
• 38 Maseri A., L'Abbate A., Baroldi G.. et al. Coronary vasospasm as a possible cause of myocardial infarction: A conclusion derived from study of preinfarction angina. New Engl. J. Med. 1978; 229: 1271-1277
• 39 Maseri A.. et al. »Variant« angina: one aspect of a continous spectrum of vasospastic myocardial ischaemia. Am. J. Cardiol. 1978; 42: 1019
• 40 Maseri A., Chierchia S., L'Abbate A.. Pathogenetic mechanism underlying the clinical events associated with atherosclerotic heart disease. Circulation 1980; 62 (Suppl. V) 3-13
• 41 Lown B., Verrier R. L.. Neural activity and ventricular fibrillation. New Engl. J. Med. 1976; 294: 1165-1170
• 42 Lown B., Verrier R. C., Rabinowitz S. J.. Neural and psychologic mechanism and the problem of sudden cardiac death. Am. J. Cardiol. 1977; 39: 890-902
• 43 Engel G. L.. Sudden death and rapid death during psychologic stress. Folklore or folk wisdom. Ann. intern. Med. 1971; 74: 771-782
• 44 Taggart P., Carruthers M., Somerville W.. Electrocardiograms. plasma catecholamines and lipids and their modification by Oxprenolol when speaking before an audience. Lancet 1973; 2: 341-346
• 45 Cobb L. A., Werner J. A.. Antiarrhythmic therapy. Ventricular depolarization and sudden death. The tip of the iceberg (editorial). Circulation 1979; 59: 864-865
• 46 Valentine P. A.. Lidocain in the prevention of sudden death in the prehospital phase of acute myocardial infarction. New Engl. J. Med. 1974; 291: 1327-1331
• 47 Singh J. B., Kocot S. L.. A controlled trial of intramuscular lidocain in the prevention of premature ventricular contractions associated with acute myocardial infarction. Am. Heart J. 1976; 91: 430
• 48 Lie K. J., Liem K. L., Louridzt W. J., Janse M. J., Willebrands A. F., Durrer D.. Efficacy of lidocain in preventing primary fibrillation within 1 hour after a 300 mg intramuscular injection. A double blind, randomized study of 300 hospitalized patients with acute myocardial infarction. Am. J. Cardiol. 1978; 42: 486
• 49 Bernstein V., Bernstein M., Griffith J.. et al. Lidocain intramusculary in acute myocardial infarction. JAMA 1972; 279: 1027-1031
• 50 Cohen L. S., Rosenthal J. E.. et al. Plasma levels of lignocaine after intramuscular administration. Am. J. Cardiol. 1972; 29: 520-523
• 51 Ryden L., Wasir H., Conradsson T. B.. et al. Blood levels of lignocaine after intramuscular administration to patients with proven or suspected acute myocardial infarction. Brit. Heart J. 1972; 34: 1012-1017
• 52 Scott D. B., Vellani C. W., Jebson P. J.. et al. Plasma levels of lignocaine after intramuscular injection. Lancet 1968; 2: 1209-1210
• 53 Zener J. C., Kerber R. E., Spivak A. P., Harrison D. C.. Blood lidocain levels and kinetics following highdose intramuscular administration. Circulation 1973; 47: 984
• 54 Ribner H. S., Isaacs E. S., Frishman W. H.. Lidocain prophylaxis against ventricular fibrillation in acute myocardial infarction. Prog. Cardio-vasc. Dis. 1979; 21: 287
• 55 Lie K. J., Wellens H. J. J., van Capelle F. J., Durrer D.. Lidocaine in the prevention of primary ventricular fibrillation. A double blind randomized study of 212 consecutive patients. New Engl. J. Med. 1974; 291: 1324
• 56 Harrison D. C. Should lidocain be administered routinely to all patients after acute myocardial infarction? (editorial). Circulation 1978; 58: 581-584
• 57 Killip T.. Arrhythmias in myocardial infarction. Med. Clin. N. Amer. 1976; 60: 233
• 58 Scheinman M. M., Remedios P., Cheitlin M. D.. et al. Effects of antiarrhythmic drugs on atrioventricular conduction in patients with acute myocardial infarction. Circulation 1980; 62: 20
• 59 Rudolph W., Dirschinger J.. Standardtherapie des akuten Myocardinfarktes. Herz 1981; 6: 1-13
• 60 Barber J. M., Mc D. C., Boyle HussainZ.. et al. Simple lignocaine regimen for transit to hospital after myocardial infarction. Brit. Heart J. 1977; 39: 1361
• 61 Ryden L., Waldenstrom A.. et al. Comparison between effectiveness of intramuscular and intravenous lignocaine on ventricular arrhythmias complicating acute myocardial infarction. Brit. Heart J. 1973; 35: 1124-1131
• 62 Campbell N. P. S., Kelly J. G., Adgey A. A. J., McDevitt D. G., Pantridge J. F.. Observations on intravenous administration of lignocaine in patients with myocardial infarction. 1978; Brit. Heart J. 40: 1371
• 63 Sheridan D. J., Crawford L., Rawlins M. D., Julian D. G.. Antiarrhythmic action of lignocaine in early myocardial infarction. Plasma levels after combined intramuscular and intravenous administration. Lancet 1977; 1: 824
• 64 Bleifeld W., Merx W., Heimich K. W., Effert S.. Lidocain zur Arrhythmieprophylaxe beim frischen Herzinfarkt. Verh. dtsch. Ges. inn. Med. 1972; 78: 1035
• 65 Jennings G., Model D. C., Jones M. B. D.. et al. Oral disopyramid in prophylaxis of arrhythmias following myocardial infarction. Lancet 1976; 1: 51
• 66 Aschuff S. C., Campbell R. W.. et al. Mexiletine in the prevention of ventricular dysrhythmias in acute myocardial infarction. Circulation 1975; 51/52 (Suppl. II) 147
• 67 Merx W., Franken G., Effert S.. Mexitil beim akuten Herzinfarkt. Z. Kardiol. 1980; 69: 204
• 68 Kosowsky B. D., Taylor J., Lown B., Ritchie R. T.. Long-term use of procainamid following acute myocardial infarction. Circulation 1973; 47: 1204-1210
• 69 Collaborative Group Phenytoin after recovery from myocardial infarction. Controlled trial in 568 patients. Lancet 2. 1971; 1055-1057
• 70 Vajda F. J. E., Prineas R. J., Lovell R. R. H., Sloman J. G.. The possible effect of longterm high plasma levels of phenytoin on mortality after acute myocardial infarction. Europ. J. Clin. Pharmacol. 1973; 5: 138
• 71 Lovell R. R. H.. Review of the present status of drug treatment for preventing sudden death. Brit. Heart J. 40 (Suppl.) 1978; 94-98
• 72 Peter Th., Ross D.. et al. Effect on survival after myocardial infarction of longterm treatment with phenytoin. Brit. Heart J. 1978; 40: 1356-1360
• 73 van Durme J. P., Bogaert M. G.. Prevention of sudden death: The role of antiarrhythmic therapy. In Kulbertus H. E., Wellens H. J. J.. (eds) Sudden death. Martinus Nijhoff-Publishers The Hague, Boston; London: 1980: 324-327
• 74 Hagemeijer F., Glaser B., van Durme J. P., Bogaert M.. Design of a study to evaluate drug therapy of serious ventricular rhythm disturbances after an acute myocardial infarction. Europ. J. Cardiol. 1977; 6: 299-310
• 75 Chamberlain D. A.. Oral mexiletine in high risk patients after acute myocardial infarction. VIII European Congress of Cardiology, Paris, 217 (abstr) 1980
• 76 Campbell N. P. S., Pantridge J. T., Adgey A. A. J.. Longterm oral antiarrhythmic therapy with mexitil. Brit. Heart. J. 1978; 40: 796-801
• 77 Lichtlen P. R., Bethge K. P., Godt U.. Zum Problem der antiarrhythmischen Langzeittherapie nach Infarkt. In Gross F.. Neue Aspekte der medikamentösen Behandlung des Herzinfarktes. Hans Huber Bern, Stuttgart; Wien: 1980: 201-219
• 78 Breithardt G., Seipel L., Loogen F.. Der akute Herztod - Bedeutung elektrophysiologischer Stimulationsverfahren. Verh. dtsch. Ges. Herz- u. Kreislaufforschg. 1980; 46: 38-64
• 79 Engel T. R., Mendizabal R., Meister S. G., Bentivoglio L. G.. Testing for ventricular tachycardia with programmed extrasystoles in sinus rhythm. Circulation 1975; 52 (Suppl. II) 178
• 80 Horowitz L. N., Josephson M. E., Farshidi A.. et al. Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimes. Circulation 1978; 58: 986
• 81 Mason J. W., Winkle R. A.. Electrode - catheter arrhythmia induction in the selection and assessment of antiarrhythmic drug therapy for recurrent ventricular tachycardia. Circulation 1978; 58: 971
• 82 Ruskin J. N., di Marco J. P., Garan H.. Out of hospital cardiac arrest. electrophysiologic observations and selecting of long term antiarrhythmic therapy. New Engl. J. Med. 1980; 303: 607-613
• 83 Warnowicz M. A., Denes P.. Chronic ventricular arrhythmias: Comparative drug effectiveness and toxicity. Progr. Cardiovasc. Dis. 1980; 23: 225-236
• 84 Zipes D. P.. New approaches to antiarrhythmic therapy. New Engl. J. Med. 1981; 304: 475-476
• 85 Wellens H. J. J., Bär F.. Clinical relevance of tachycardias induced during programmed cardiac stimulation. Am. J. Cardiol. 1979; 43: 400 (abstr.)
• 86 Fisher D. H.. Ventricular tachycardia - practical and provocative electrophysiology (editorial):. Circulation 1978; 58: 1000
• 87 Breithardt G., Seipel L., Haerten H., Abend-rot L., Loogen R.. Effektivitätskontrolle der antiarrhythmischen Therapie bei Patienten mit chronisch rezidivierenden, ventrikulären Tachykardien mittels elektrophysiologischer Stimulationsverfahren. Z. Kardiol. 1979; 68: 725
• 88 Collins jr. J. J.. Surgery for intractable ventricular arrhythmias. New Engl. J. Med. 1980; 302: 627-628
• 89 Fontaine G., Frank R., Guiraudon G.. et al. Surgical treatment of resistant reentrant ventricular tachycardia by ventriculotomy. A new application of epicardial mapping. Circulation 1974; 49/50 (Suppl. III) 82
• 90 Guiraudon G., Fontaine G., Frank R.. Circular endocardial ventriculotomie.A new surgical treatment for life threatening ventricular tachycardia resistant to medical treatment following myocardial infarction. Ann. Thoracic. Surg. 1978; 26: 438
• 91 Kaiser G. A., Waldo A. L., Beach P. M.. et al. Specialized cardiac conduction-system. Improved electrophysiologic identification technique at surgery. Arch. Surg. 1970; 101: 673
• 92 Lown B., Th B.Graboys. Management of patients with malignant ventricular arrhythmias. Am. J. Cardiol. 1977; 39: 910-918
• 93 Hjalmarson A.. Prevention of sudden death. The role of Betablockers. In Kulbertus H. E., Wellens H. J. J.. Sudden death. Martinus Nijhoff-Publishers. The Hague; Bosten, London: 1980: 313-323
• 94 A Multicenter International Study Improvement in prognosis of myocardial infarction by longterm betaadrenoreceptor blockade using practolol. Brit. med. J. 1977; 735-740 III
• 95 Multicentre International Study Supplementary report: Reduction in mortality after myocardial infarction with longterm betaadrenoreceptor-blockade (K. G. Green). Brit. med. J. 1977; II 419-421
• 96 Schröder R.. Prävention des Reinfarktes und des plötzlichen Herztodes. In Gross F.. Neue Aspekte der medikamentösen Behandlung des Herzinfarktes. Hans Huber, Bern; Stuttgart, Wien: 1980: 165-177
• 97 Barber J. M., Boyle M. C.. et al. Practolol in acute myocardial infarction. Acta med. Scand. Suppl. 1976; 587: 213-216
• 98 Ahlmark G., Saetre H.. Longterm treatment with betablockers after myocardial infarction. Europ. J. Clin. Pharmacol. 1976; 10: 77
• 99 Ahlmark G., Saetre H., Korsgren M.. Reduction of sudden death after myocardial infarction. Lancet 1974; 2: 1563
• 100 Andersen M. P., Bechsgaard P., Frederikse J.. et al. Effect of alprenolol on mortality among patients with definitive or suspected myocardial infarction. Preliminary results. Lancet 1979; 2: 865-868
• 101 Reynolds J. L., Whitelock R. M. L.. Effects of a beta adrenergic receptorblocker in myocardial infarction treated for one year from onset. Brit. Heart J. 1972; 34: 252
• 102 Wilhelmsson C, Vedin J. A., Wilhemsen L., Tibblin G., Werkö L.. Reduction of sudden death after myocardial infarction by treatment with alprenolol. Lancet 1974; 2: 1157
• 103 Vedin A., Wilhelmsson C., Tibblin G., Werkö L.. Chronic alprenolol treatment of patients with acute myocardial infarction after discharge from hospital. Acta. med. Scand. Suppl. 1975; 575: 7
• 104 Baber N. S.. et al. Multicentre postinfarction trial of propranolol in 49 hospitals in the United Kingdom, Italy and Yugoslavia. Brit. Heart J. 1980; 44: 96-100
• 105 Sloman G., Stannard M.. Beta adrenergic blockade and cardiac arrhythmia. Brit. med. J. 1967; 508. IV
• 106 Winkle R. A., Gradman A. H., Fitzgerald J. W.. Antiarrhythmic drug effect assessed from ventri-cular anhythmia reduction in the ambulatory electrocardiogram and tread mill test: Comparison of propranolol, procainamid and quinidine. Am. J. Cardiol. 1978; 42: 473
• 107 Sinn R., Wolf R., Pretschner P., Hundesha-gen H., Koeffler H., Dopslaff H.. Häufigkeit und Bedeutung ventrikulärer Arrhythmien unter medikamentöser Prophylaxe nach Myocardinfarkt. Z. Kardiol. 1980; 69: 225
• 108 Godt U., Bethge K. P., Lichtlen P. R.. Rhythmusstörungen und plötzlicher Herztod im frühen Postinfarktstadium. Z. Kardiol. 1980; 69: 226
• 109 Wellens H. J. J., Bär F., Lie K. J.. et al. Effect of procainamid, propranolol and verapamil on mechanism of tachycardia in patients with chronic recurrent ventricular tachycardia. Am. J. Cardiol. 1977; 40: 579
• 110 Ritchie J. L., Harker L. A.. The possible role of platelets in sudden cardiac death. In Kulbertus H. E., Wellens H. J. J.. Sudden death. Martinus Nijhoff-Publishers; The Hague, Boston, London: 1980: 328-334
• 111 Overschl K. W., So Baedecker C. S.. Wirkung von Betarezeptorenblockern auf die Thrombozytenaggregation bei coronarer Herzkrankheit. Z. Kardiol. Suppl. 1978; 5: 78
• 112 Sherry S.. The Anturan Reinfarction Trial. Circulation 1980; 62: 73-78 (Suppl/V)
• 113 Gülker R. F., Bender J.Thaler, Heuer R., Dorsel T., Pierchalter P.. Fehlende antiarrhythmische und antifibrillatorische Wirkung von Sul-finpyrazolon beim akuten Myocardinfarkt. Z. Kardiol. 1980; 69: 206
• 114 Moschos C., Escobias A., Jorgensen O., Regan T.. Effect of sulfinpyrazon on survival following experimental non thrombotic coronary occlusion. Am. J. Cardiol. 1979; 43: 372
• 115 Wilcox R. G., Richardson D., Hampton J. R., Mitchell J. R. A., Banks D. C.. Sulfinpyrazon in acute myocardial infarction: Studies on cardiac rhythm and renal function. Brit. med. J. 1980; 281: 531